TIDMAMC

RNS Number : 9541S

Amur Minerals Corporation

14 July 2020

14 July 2020

Amur Minerals Corporation

("Amur" or "the Company")

Response to Price Movement

Amur Minerals Corporation ("Amur" or the "Company"), the nickel-copper sulphide mineral exploration and resource development company focused on the far east of Russia, notes the recent movement in its share price and confirms that it is considering an investment in the mining sector and that this investment is subject to completion of the due diligence and funding. The investment is in accordance with the Company's stated intention of acquiring interests in financial instruments within the mining sector to provide the Company with a reliable source of income going forward, or where the Company will be able to add short to medium-term value and does not constitute a reverse takeover.

The Company will make further announcements as discussions progress.

Enquiries:

 
       Company            Nomad and Broker        Public Relations 
  Amur Minerals Corp.    S.P. Angel Corporate        Blytheweigh 
                             Finance LLP 
   Robin Young CEO        Richard Morrison           Megan Ray 
                            Soltan Tagiev            Tim Blythe 
                           +44 (0) 20 3470 
  +7 (4212) 75 56 15             0470           +44 (0) 20 7138 3204 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

SPMKZLBFBDLEBBB

(END) Dow Jones Newswires

July 14, 2020 05:55 ET (09:55 GMT)

Crism Therapeutics (AQSE:AMC.GB)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Crism Therapeutics Charts.
Crism Therapeutics (AQSE:AMC.GB)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Crism Therapeutics Charts.